Literature DB >> 19188451

Estrogen receptor alpha represses transcription of early target genes via p300 and CtBP1.

Fabio Stossi1, Zeynep Madak-Erdogan, Benita S Katzenellenbogen.   

Abstract

The regulation of gene expression by nuclear receptors controls the phenotypic properties and diverse biologies of target cells. In breast cancer cells, estrogen receptor alpha (ERalpha) is a master regulator of transcriptional stimulation and repression, yet the mechanisms by which agonist-bound ERalpha elicits repression are poorly understood. We analyzed early estrogen-repressed genes and found that ERalpha is recruited to ERalpha binding sites of these genes, albeit more transiently and less efficiently than for estrogen-stimulated genes. Of multiple cofactors studied, only p300 was recruited to ERalpha binding sites of repressed genes, and its knockdown prevented estrogen-mediated gene repression. Because p300 is involved in transcription initiation, we tested whether ERalpha might be trying to stimulate transcription at repressed genes, with ultimately failure and a shift to a repressive program. We found that estrogen increases transcription in a rapid but transient manner at early estrogen-repressed genes but that this is followed by recruitment of the corepressor CtBP1, a p300-interacting partner that plays an essential role in the repressive process. Thus, at early estrogen-repressed genes, ERalpha initiates transient stimulation of transcription but fails to maintain the transcriptional process observed at estrogen-stimulated genes; rather, it uses p300 to recruit CtBP1-containing complexes, eliciting chromatin modifications that lead to transcriptional repression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19188451      PMCID: PMC2655624          DOI: 10.1128/MCB.01476-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

1.  CtBP represses p300-mediated transcriptional activation by direct association with its bromodomain.

Authors:  Jae-Hwan Kim; Eun-Jung Cho; Seong-Tae Kim; Hong-Duk Youn
Journal:  Nat Struct Mol Biol       Date:  2005-04-17       Impact factor: 15.369

Review 2.  Controlling nuclear receptors: the circular logic of cofactor cycles.

Authors:  Valentina Perissi; Michael G Rosenfeld
Journal:  Nat Rev Mol Cell Biol       Date:  2005-07       Impact factor: 94.444

Review 3.  Enhanced histone acetylation and transcription: a dynamic perspective.

Authors:  Alison L Clayton; Catherine A Hazzalin; Louis C Mahadevan
Journal:  Mol Cell       Date:  2006-08-04       Impact factor: 17.970

4.  Reconstitution of chromatin transcription with purified components reveals a chromatin-specific repressive activity of p300.

Authors:  Buyung Santoso; James T Kadonaga
Journal:  Nat Struct Mol Biol       Date:  2006-01-15       Impact factor: 15.369

5.  p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation.

Authors:  W L Kraus; J T Kadonaga
Journal:  Genes Dev       Date:  1998-02-01       Impact factor: 11.361

6.  Estrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a repressor complex at the cyclin G2 promoter.

Authors:  Fabio Stossi; Varsha S Likhite; John A Katzenellenbogen; Benita S Katzenellenbogen
Journal:  J Biol Chem       Date:  2006-04-10       Impact factor: 5.157

7.  Corepressor CtBP1 interacts with and specifically inhibits CBP activity.

Authors:  Vitalyi Senyuk; Kislay Kumar Sinha; Giuseppina Nucifora
Journal:  Arch Biochem Biophys       Date:  2005-09-15       Impact factor: 4.013

8.  Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells.

Authors:  Jonna Frasor; Fabio Stossi; Jeanne M Danes; Barry Komm; C Richard Lyttle; Benita S Katzenellenbogen
Journal:  Cancer Res       Date:  2004-02-15       Impact factor: 12.701

Review 9.  Therapeutic targeting in the estrogen receptor hormonal pathway.

Authors:  Benita S Katzenellenbogen; Jonna Frasor
Journal:  Semin Oncol       Date:  2004-02       Impact factor: 4.929

10.  Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors.

Authors:  Fabio Stossi; Daniel H Barnett; Jonna Frasor; Barry Komm; C Richard Lyttle; Benita S Katzenellenbogen
Journal:  Endocrinology       Date:  2004-03-19       Impact factor: 4.736

View more
  33 in total

1.  Histone deacetylase inhibitors suppress transdifferentiation of gonadotrophs to prolactin cells and proliferation of prolactin cells induced by diethylstilbestrol in male mouse pituitary.

Authors:  Nandar Tun; Yasuaki Shibata; Myat Thu Soe; Myo Win Htun; Takehiko Koji
Journal:  Histochem Cell Biol       Date:  2018-12-03       Impact factor: 4.304

2.  An ADIOL-ERβ-CtBP transrepression pathway negatively regulates microglia-mediated inflammation.

Authors:  Kaoru Saijo; Jana G Collier; Andrew C Li; John A Katzenellenbogen; Christopher K Glass
Journal:  Cell       Date:  2011-05-13       Impact factor: 41.582

3.  Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer.

Authors:  Dyah L Dewi; Soumya R Mohapatra; Saioa Blanco Cabañes; Isabell Adam; Luis F Somarribas Patterson; Bianca Berdel; Masroor Kahloon; Loreen Thürmann; Stefanie Loth; Katharina Heilmann; Dieter Weichenhan; Oliver Mücke; Ines Heiland; Pauline Wimberger; Jan Dominik Kuhlmann; Karl-Heinz Kellner; Sarah Schott; Christoph Plass; Michael Platten; Clarissa Gerhäuser; Saskia Trump; Christiane A Opitz
Journal:  Oncoimmunology       Date:  2017-01-03       Impact factor: 8.110

4.  Phosphorylation by p38 mitogen-activated protein kinase promotes estrogen receptor α turnover and functional activity via the SCF(Skp2) proteasomal complex.

Authors:  Shweta Bhatt; Zhen Xiao; Zhaojing Meng; Benita S Katzenellenbogen
Journal:  Mol Cell Biol       Date:  2012-03-19       Impact factor: 4.272

Review 5.  Steroid hormone receptors as prognostic markers in breast cancer.

Authors:  Maggie C Louie; Mary B Sevigny
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

6.  A MicroRNA196a2* and TP63 circuit regulated by estrogen receptor-α and ERK2 that controls breast cancer proliferation and invasiveness properties.

Authors:  Kyuri Kim; Zeynep Madak-Erdogan; Rosa Ventrella; Benita S Katzenellenbogen
Journal:  Horm Cancer       Date:  2012-12-19       Impact factor: 3.869

7.  Designer monotransregulators provide a basis for a transcriptional therapy for de novo endocrine-resistant breast cancer.

Authors:  Stephanie L Nott; Yanfang Huang; Aja Kalkanoglu; Kathryn Harper; Ming Chen; Scott F Paoni; Bruce M Fenton; Mesut Muyan
Journal:  Mol Med       Date:  2009-11-17       Impact factor: 6.354

8.  The oncoprotein HBXIP modulates the feedback loop of MDM2/p53 to enhance the growth of breast cancer.

Authors:  Hang Li; Qian Liu; Zhen Wang; Runping Fang; Yu Shen; Xiaoli Cai; Yuen Gao; Yinghui Li; Xiaodong Zhang; Lihong Ye
Journal:  J Biol Chem       Date:  2015-07-30       Impact factor: 5.157

9.  Systematic nucleo-cytoplasmic trafficking of proteins following exposure of MCF7 breast cancer cells to estradiol.

Authors:  Gabriella Pinto; Abdulrab Ahmed M Alhaiek; Sepan Amadi; Amal T Qattan; Mark Crawford; Marko Radulovic; Jasminka Godovac-Zimmermann
Journal:  J Proteome Res       Date:  2014-01-24       Impact factor: 4.466

Review 10.  Transcription factor co-repressors in cancer biology: roles and targeting.

Authors:  Sebastiano Battaglia; Orla Maguire; Moray J Campbell
Journal:  Int J Cancer       Date:  2010-06-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.